Home » Healthcare » Adrenocorticotropic Hormone Market

Adrenocorticotropic Hormone Market By Source (Natural, Synthetic) By Application (Rheumatology, Neurology, Nephrotic Syndrome, Ophthalmology, Others) By End-Users (Hospitals, Specialty Clinics, Homecare, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Published: | Report ID: 19255 | Report Format : PDF

Key Highlights of the Report

The global Adrenocorticotropic Hormone Market is classified according to the source, application, end-user, distribution channel, and geography. The hospital pharmacy category accounts for the majority of market share, with synthetic and natural being the two leading source sectors. The ophthalmology category is expected to increase considerably in the next years, with hospitals and specialist clinics governing limited market demand and North America dominating market expansion.

Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is becoming more popular, driving the global Adrenocorticotropic Hormone Market. Furthermore, ACTH testing are costly and unreimbursed, and adrenal gland problems are undervalued. However, the market also confronts substantial hurdles, such as high treatment costs and a lack of therapeutic options.

Nonetheless, the global Adrenocorticotropic Hormone Market provides considerable potential opportunities, including the fact that adrenal gland issues are growing more widespread, and ACTH testing are getting more popular in emerging nations. Furthermore, the growing usage of ACTH testing in underdeveloped countries is bringing up new opportunities in the ACTH sector.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

What Are the Primary Forces Driving the Global Adrenocorticotropic Hormone Market?

Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is becoming more popular, driving the global Adrenocorticotropic Hormone Market.

What Are the Global Adrenocorticotropic Hormone Market’s Major Challenges?

The global Adrenocorticotropic Hormone Market also confronts various problems, including high treatment costs and a lack of therapeutic options.

What Are the Opportunities for Growth in the Global Adrenocorticotropic Hormone Market?

Adrenal gland issues are getting more widespread, and ACTH testing are becoming more popular in developing nations, hence the global Adrenocorticotropic Hormone Market provides considerable potential opportunities.

Executive Summary

Overview of the Global Adrenocorticotropic Hormone Market

The adrenocorticotropic hormone (ACTH) market is the market for the pituitary gland’s hormone, which stimulates the adrenal glands to create cortisol, a steroid hormone that helps control the body’s response to stress. The ACTH market comprises a wide range of tests and therapies for this hormone.

Adrenocorticotropic Hormone Market

Market Definition

The adrenocorticotropic hormone (ACTH) market is the market for the pituitary gland hormone that stimulates the adrenal glands to create cortisol, a steroid hormone that helps control the body’s response to stress.Because of the rising frequency of adrenal gland illnesses such as Addison’s disease and Cushing’s syndrome, which are detected via ACTH testing, the global Adrenocorticotropic hormone (ACTH) market is predicted to rise at a high rate. The increased need for ACTH testing in hospitals, diagnostic laboratories, and research centres is also driving the market.

Market Insights

  • The global demand for Adrenocorticotropic Hormones was valued at USD 1.5 Billion in 2022 and is expected to reach USD 1.98 Billion in 2030, growing at a CAGR of 4.10% between 2023 and 2030.
  • The synthetic segment dominates the Adrenocorticotropic hormone market, the Natural segment is the second largest source in the coming years
  • In 2022, the Nephrotic Syndrome category is predicted to develop at a 7.3% CAGR; the ophthalmology segment is likely to expand dramatically in the next years.
  • The Hospital segment governs the demand for Adrenocorticotropic Hormones in the world, the Specialty Clinics segment contributes the rest to the demand.
  • The Hospital Pharmacy category has the biggest market share, The online pharmacy category is the market’s least demanding distribution channel.
  • North America accounts for roughly 40% of the Adrenocorticotropic hormone market, Asia-Pacific is the market’s fastest-growing regional segment.
  • Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is becoming more popular, which are the main market drivers.
  • The key constraints are that ACTH testing are expensive and unreimbursed, and adrenal gland problems are undervalued.
  • Adrenal gland issues are growing more widespread, and ACTH tests are becoming more popular in developing nations, creating significant market prospects.

Adrenocorticotropic Hormones Market

Market Overview

The global Adrenocorticotropic Hormone Market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 4.10% between 2023 and 2030. The market was valued at USD 1.5 Billion in 2022 and is expected to reach USD 1.98 Billion in 2030.

Segmentation by Source

  • The synthetic segment dominates the Adrenocorticotropic hormone market.
  • The Natural segment is the second largest source in the coming years.

Segmentation by Application

  • In 2022, the Nephrotic Syndrome category is predicted to develop at a 7.3% CAGR
  • The ophthalmology segment is likely to expand dramatically in the next years.

Segmentation by End-User

  • The Hospital segment governs the demand for Adrenocorticotropic Hormones in the world.
  • The Specialty Clinics segment contributes the rest to the demand for Adrenocorticotropic Hormones.

Segmentation by Distribution Channel

  • The Hospital Pharmacy category has the biggest market share.
  • The online pharmacy category is the market’s least demanding distribution channel.

Segmentation by Region

  • North America accounts for roughly 40% of the Adrenocorticotropic hormone market.
  • Asia-Pacific is the market’s fastest-growing regional segment.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Adrenocorticotropic Hormones.

Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is gaining popularity. However, the market is hampered by the fact that ACTH testing are costly and unreimbursed, and adrenal gland problems are undervalued.

North America has the biggest market share due to the presence of well-established healthcare infrastructure, the increasing frequency of adrenal gland illnesses, and the rising need for sophisticated diagnostic procedures. Europe is the second-largest market for ACTH, owing to an increase in autoimmune illnesses and an aging population.

The Asia Pacific region is predicted to grow rapidly due to rising awareness of adrenal gland problems, rising healthcare expenditure, and increased government measures to promote healthcare infrastructure. Due to the increasing prevalence of adrenal gland illnesses and the rising demand for enhanced diagnostic tools, Latin America, the Middle East, and Africa are also predicted to develop steadily.

Overall, the growing demand for Adrenocorticotropic Hormones can be related to the fact that Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is gaining popularity.

Market Drivers

The global Adrenocorticotropic Hormone Market is driven by several factors. The following are the key drivers of the global Adrenocorticotropic Hormone Market:

Increasing Interest in Personalized Medicine

Personalized medicine is a method that involves adapting medical therapy to each patient’s unique traits. Because of the variety in ACTH and cortisol production among patients with endocrine diseases, this strategy is becoming increasingly popular in the Adrenocorticotropic hormone market. Personalized medicine enables the selection of the most effective treatment for each patient, perhaps leading to better outcomes and fewer side effects.

Technological advancements such as genome sequencing and biomarker discovery have enabled the development of personalized therapy in the Adrenocorticotropic hormone industry. While genome sequencing may be used to find genetic variances that may affect treatment results, biomarkers can be used to identify individuals who are most likely to react to treatment.

As pharmaceutical companies invest in the development of novel treatments and diagnostic tests that are tailored to the particular needs of each patient, the market for adrenocorticotropic hormones is likely to rise. By reducing the need for trial-and-error treatment procedures, this approach has the potential to enhance patient outcomes while also lowering healthcare expenditures.

Hormone Replacement Therapy is becoming increasingly popular.

The Adrenocorticotropic hormone (ACTH) industry is being driven by increased demand for hormone replacement treatment (HRT). HRT is a hormone replacement therapy that replaces hormones that the body no longer produces after menopause or as a result of other diseases such as Addison’s disease. ACTH is utilized to promote the production of cortisol, which is frequently substituted in HRT. The growing demand for HRT is pushing up the demand for ACTH tests, which are used to monitor cortisol levels in HRT patients.

Moreover, around 1.3 million American women use HRT to manage menopausal symptoms such as vaginal dryness, hot flashes, and mood swings. The growing demand for HRT is pushing up the demand for ACTH tests, which are used to monitor cortisol levels in HRT patients.

The ACTH market is predicted to expand rapidly due to rising demand for these tests in hospitals, diagnostic laboratories, and research facilities. Because of the high frequency of adrenal gland problems and increased demand for HRT in the region, North America is likely to be the largest market for ACTH testing.

Market Restraints

The global Adrenocorticotropic Hormone Market faces some challenges that may hinder its growth. These include the following:

ACTH Tests are Expensive and Unreimbursed

The high cost of adrenocorticotropic hormone (ACTH) testing, as well as their lack of reimbursement, is stifling the ACTH industry. ACTH tests are costly, and the lack of reimbursement makes it difficult for patients to afford them. The cost of an ACTH test ranges from $100 to $500, according to a research published in the Journal of Clinical Endocrinology and Metabolism, depending on the region and laboratory that administers the test. The high expense of these tests is a substantial obstacle for patients who require them, particularly those who are uninsured or have limited coverage.

Furthermore, patients are finding it difficult to purchase these tests due to a lack of reimbursement. ACTH tests are not covered by Medicare in the United States, and private insurance companies have various policies regarding their coverage.

The high costs of ACTH testing, as well as a lack of reimbursement for these tests, are limiting the ACTH market. The high cost of these tests limits the number of patients who can afford them, and the lack of reimbursement limits the number of tests performed. As a result, the ACTH market is expected to expand at a slower pace than previously predicted.

Adrenal Gland Disorders Are Underappreciated

The Adrenocorticotropic hormone (ACTH) market is being hampered by a lack of understanding about adrenal gland problems. Adrenal gland problems are uncommon, and the majority of individuals are unaware of their symptoms, causes, and therapies.  Adrenal gland diseases impact around one in every 10,000 persons globally, according to the National Institutes of Health (NIH). These conditions can result in a variety of symptoms such as weariness, weight loss, muscle weakness, and low blood pressure.

The lack of understanding about adrenal gland problems makes it difficult for people to be recognized and treated. Many people with adrenal gland diseases are misdiagnosed as having other ailments, resulting in treatment delays and avoidable suffering.

In addition, because of the lack of knowledge about adrenal gland problems, it is difficult for healthcare personnel to identify people who require ACTH tests. Many doctors are unaware of the symptoms of adrenal gland problems or the relevance of ACTH testing in their diagnosis and therapy.

Opportunities

The global Adrenocorticotropic Hormone Market offers significant growth opportunities. These include the following:

The rising prevalence of adrenal gland disorders is driving the demand for ACTH tests.

The rising prevalence of adrenal gland problems is driving up demand for adrenocorticotropic hormone (ACTH) assays, providing potential in the ACTH market. Adrenal gland problems are growing more common around the world as a result of causes such as aging populations, pollution, and lifestyle changes. The global adrenal gland disorders therapeutics market was worth USD 1.7 billion in 2019 and is predicted to increase at a CAGR of 9.8% between 2022 and 2030. The increasing prevalence of adrenal gland illnesses is driving demand for ACTH testing and other diagnostic tools, which is driving this growth.

Furthermore, rising awareness of adrenal gland problems is increasing demand for ACTH tests. Patients and doctors are becoming increasingly aware of the symptoms of adrenal gland problems, as well as the relevance of ACTH testing in their diagnosis and treatment. The rising prevalence of adrenal gland problems is driving up demand for ACTH diagnostics, providing potential in the ACTH market. Growing demand is predicted to encourage innovation in the creation of new and improved ACTH tests, as well as increasing investment in R&D.

ACTH Tests Are Becoming More Popular in Developing Countries

Adrenocorticotropic hormone (ACTH) testing is becoming more popular in developing countries, which is opening up new potential in the ACTH market. Rapid economic expansion and urbanization in developing countries are driving demand for healthcare services, particularly diagnostic tests. Noncommunicable diseases (NCDs) such as diabetes, cardiovascular disease, and cancer are growing more common in developing nations, according to a World Health Organization (WHO) research. Because these diseases are frequently connected with adrenal gland abnormalities, there is an increased demand for ACTH assays and other diagnostic tools.

In addition, the growing availability of ACTH testing in underdeveloped nations is promoting acceptance. Many healthcare providers in underdeveloped nations now have access to ACTH tests that were previously unavailable or prohibitively expensive. As a result, a rising number of patients are being diagnosed and treated for adrenal gland illnesses.

The increasing use of ACTH testing in developing nations is opening up new prospects in the ACTH industry. greater demand is projected to spur innovation in the creation of new and improved ACTH tests, as well as greater investment in R&D.

Competitive Landscape

Key Players

The global Adrenocorticotropic Hormone Market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Hikma Pharmaceuticals PLC (UK)
  • Merck & Co., Inc. (US)
  • Mallinckrodt (US)
  • Avantor, Inc. (US)
  • Merck KGaA (Germany)
  • Ferring B.V. (Switzerland)
  • Viatris, Inc. (US)
  • Others

These companies focus on product innovation, expanding their distribution channels, and mergers and acquisitions to stay ahead in the market.

The major players in the global Adrenocorticotropic Hormone Market are constantly striving to stay ahead by introducing new products and innovations.

In 2020, Quest Diagnostics announced the release of a new ACTH test that measures ACTH levels in the blood using mass spectrometry technology. This test is designed to give patients with adrenal gland problems with more accurate and trustworthy results.

Pfizer Inc. gained FDA approval in 2019 for Infacort, a novel ACTH gel. This gel is intended to treat infants and children with adrenal gland diseases, and it is anticipated that it will provide a more convenient and effective therapy alternative for this patient population.

Novartis AG announced the release of Sogroya, a novel ACTH gel, in 2019. This gel is intended to treat individuals suffering from growth hormone insufficiency and is predicted to be a more convenient and effective treatment choice for this patient population.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • Adrenal Gland Disorders are getting more common, and Hormone Replacement Therapy is becoming more popular driving market growth
  • Market segmented by Source, application, End-User, distribution channel, and region.
  • In 2022, the Nephrotic Syndrome category is predicted to develop at a 7.3% CAGR
  • The Hospital segment governs the demand for Adrenocorticotropic Hormones in the world.
  • North America is leading market growth; the market is highly competitive with key players including Novartis AG, Hikma Pharmaceuticals PLC, Merck & Co., Inc. and Mallinckrodt.

Future Outlook

  • The increasing use of ACTH testing in developing nations is opening up new prospects in the ACTH industry.
  • Technological advances will promote innovation in the creation of new and improved ACTH assays.
  • The pandemic of COVID-19 has had little effect on the ACTH market, with demand staying constant.
  • The largest market for ACTH is North America, followed by Europe and Asia Pacific. Ferring Pharmaceuticals, Pfizer, Inc., and Novartis AG are among the major participants in the ACTH market.

Segmentation

  • By Source
    • Natural
    • Synthetic
  • By Application
    • Rheumatology
    • Neurology
    • Nephrotic Syndrome
    • Ophthalmology
    • Others
  • By End-Users
    • Hospitals
    • Specialty Clinics
    • Homecare
    • Others
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
    • Others
  • By Region
  • North America
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – DataModelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Adrenocorticotropic hormone market
2.2. Global Adrenocorticotropic hormone market, By Source
2.3. Global Adrenocorticotropic hormone market, By Application
2.4. Global Adrenocorticotropic hormone market, By End-User
2.5. Global Adrenocorticotropic hormone market, By Distribution Channel
2.6. Global Adrenocorticotropic hormone market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Adrenocorticotropic hormone market Value, 2017-2030, (US$ Billions)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Source
3.5.2. Application
3.5.3. End-User
3.5.4. Distribution Channel
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Source Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Source Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Adrenocorticotropic hormone market, By Source
7.1. Global Adrenocorticotropic hormone market Overview, By Source
7.1.1. Global Adrenocorticotropic hormone market Revenue Share, By Source, 2022 Vs 2030 (in %)
7.2. Natural
7.2.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
7.3. Synthetic
7.3.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)

8. Global Adrenocorticotropic hormone market, By Application
8.1. Global Adrenocorticotropic hormone market Overview, By Application
8.1.1. Global Adrenocorticotropic hormone market, By Application, 2022 vs. 2030 (in%)
8.2. Rheumatology
8.2.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
8.3. Neurology
8.3.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
8.4. Nephrotic Syndrome
8.4.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
8.5. Ophthalmology
8.5.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
8.6. Others
8.6.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)

9. Global Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
9.1. Global Adrenocorticotropic hormone market Overview, By End-User
9.1.1. Global Adrenocorticotropic hormone market, By End-User, 2022 vs 2030 (in%)
9.2. Hospitals
9.2.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
9.3. Specialty Clinics
9.3.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
9.4. Homecare
9.4.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
9.5. Others
9.5.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)

10. Global Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
10.1 Global Adrenocorticotropic hormone market Overview, By Distribution Channel
10.1.1. Global Adrenocorticotropic hormone market, By Distribution Channel, 2022 vs 2030 (in %)
10.2. Hospitals Pharmacy
10.2.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
10.3. Retail Pharmacy
10.3.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
10.4. Online Pharmacy
10.4.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)
10.5. Others
10.5.1. Global Adrenocorticotropic hormone market, By Region, 2017-2030 (US$ Billions)

11. Global Adrenocorticotropic hormone market, By Region
11.1. Global Adrenocorticotropic hormone market Overview, by Region
11.1.1. Global Adrenocorticotropic hormone market, By Region, 2022 vs 2030 (in%)
11.2. Source
11.2.1. Global Adrenocorticotropic hormone market, By Source, 2017-2030 (US$ Billions)
11.3. Application
11.3.1. Global Adrenocorticotropic hormone market, By Application, 2017-2030 (US$ Billions)
11.4. End-User
11.4.1. Global Adrenocorticotropic hormone market, By End-User, 2017-2030 (US$ Billions)
11.5. Distribution Channel
11.5.1. Global Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030 (US$ Billions)

12. North America Adrenocorticotropic hormone market Analysis
12.1. North America Adrenocorticotropic hormone market, By Source, 2017-2030(US$ Billions)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Adrenocorticotropic hormone market, By Application, 2017-2030(US$ Billions)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Adrenocorticotropic hormone market, by Country, 2017-2030(US$ Billions)
12.5.1. North America Adrenocorticotropic hormone market, by Country, 2022 Vs 2030 (in %)
12.5.2. U.S.
12.5.2.1. U.S. Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
12.5.2.2. U.S. Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
12.5.2.3. U.S. Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
12.5.2.4. U.S. Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
12.5.2.5. U.S. Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
12.5.3. Canada
12.5.3.1. Canada Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
12.5.3.2. Canada Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
12.5.3.3. Canada Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
12.5.3.4. Canada Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
12.5.3.5. Canada Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
12.5.4. Mexico
12.5.4.1. Mexico Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030 (US$ Billions)
12.5.4.2. Mexico Adrenocorticotropic hormone, By Source, 2017-2030 (US$ Billions)
12.5.4.3. Mexico Adrenocorticotropic hormone, By Application, 2017-2030 (US$ Billions)
12.5.4.4. Mexico Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
12.5.4.5. Mexico Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)

13. Europe Adrenocorticotropic hormone market Analysis
13.1. Europe Adrenocorticotropic hormone market, By Source, 2017-2030(US$ Billions)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Adrenocorticotropic hormone market, By Application, 2017-2030(US$ Billions)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Adrenocorticotropic hormone market, by Country, 2017-2030(US$ Billions)
13.5.1. EuropeAdrenocorticotropic hormone market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.2.2. Germany Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.2.3. Germany Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.3. Germany Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.4. Germany Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
13.5.5. France
13.5.5.1. France Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.5.2. France Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.5.3. France Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.5.4. France Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.5.5. France Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
13.5.6. UK
13.5.6.1. UK Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.6.2. UK Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.6.3. UK Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.6.4. UK Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.6.5. UK Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
13.5.7. Italy
13.5.7.1. Italy Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.7.2. Italy Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.7.3. Italy Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.7.4. Italy Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.7.5. Italy Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
13.5.8. Spain
13.5.8.1. Spain Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.8.2. Spain Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.8.3. Spain Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.8.4. Spain Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.8.5. Spain Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
13.5.9. Rest of Europe
13.5.9.1. Rest of Europe Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.9.2. Rest of Europe Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
13.5.9.3. Rest of Europe Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
13.5.9.4. Rest of Europe Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
13.5.9.5. Rest of Europe Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)

14. Asia Pacific Adrenocorticotropic hormone market Analysis
14.1. Asia Pacific Adrenocorticotropic hormone market, By Source, 2017-2030(US$ Billions)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Adrenocorticotropic hormone market, By Application, 2017-2030(US$ Billions)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Adrenocorticotropic hormone market, by Country, 2017-2030(US$ Billions)
14.5.1. Asia PacificAdrenocorticotropic hormone market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.2.2. China Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.2.3. China Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.2.4. China Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.2.5. China Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
14.5.3. Japan
14.5.3.1. Japan Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.3.2. Japan Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.3.3. Japan Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.3.4. Japan Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.3.5. Japan Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
14.5.4. India
14.5.4.1. India Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.4.2. India Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.4.3. India Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.4.4. India Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.4.5. India Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
14.5.5. South Korea
14.5.5.1. South Korea Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.5.2. South Korea Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.5.3. South Korea Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.5.4. South Korea Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.5.5. South Korea Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.6.2. South-East Asia Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.6.3. South-East Asia Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.6.4. South-East Asia Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.6.5. South-East Asia Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.7.2. Rest of Asia Pacific Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
14.5.7.3. Rest of Asia Pacific Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
14.5.7.4. Rest of Asia Pacific Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
14.5.7.5. Rest of Asia Pacific Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)

15. Latin America Adrenocorticotropic hormone market Analysis
15.1. Latin America Adrenocorticotropic hormone market, By Source, 2017-2030(US$ Billions)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Adrenocorticotropic hormone market, By Application, 2017-2030(US$ Billions)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Adrenocorticotropic hormone market, by Country, 2017-2030(US$ Billions)
15.5.1. LatinAmerica Adrenocorticotropic hormone market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.2.2. Brazil Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
15.5.2.3. Brazil Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
15.5.2.4. Brazil Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
15.5.2.5. Brazil Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
15.5.3. Argentina
15.5.3.1. Argentina Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.3.2. Argentina Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
15.5.3.3. Argentina Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
15.5.3.4. Argentina Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
15.5.3.5. Argentina Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.4.2. Rest of Latin America Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
15.5.4.3. Rest of Latin America Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
15.5.4.4. Rest of Latin America Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
15.5.4.5. Rest of Latin America Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)

16. Middle East and Africa Adrenocorticotropic hormone market Analysis
16.1. Middle East and Africa Adrenocorticotropic hormone market, By Source, 2017-2030(US$ Billions)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Adrenocorticotropic hormone market, By Application, 2017-2030(US$ Billions)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Adrenocorticotropic hormone market, By End-User, 2017-2030(US$ Billions)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Adrenocorticotropic hormone market, By Distribution Channel, 2017-2030(US$ Billions)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Adrenocorticotropic hormone market, by Country, 2017-2030(US$ Billions)
16.5.1. Middle East and AfricaAdrenocorticotropic hormone market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.2.2. GCC Countries Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
16.5.2.3. GCC Countries Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
16.5.2.4. GCC Countries Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
16.5.2.5. GCC Countries Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
16.5.3. South Africa
16.5.3.1. South Africa Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.3.2. South Africa Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
16.5.3.3. South Africa Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
16.5.3.4. South Africa Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
16.5.3.5. South Africa Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Adrenocorticotropic hormone market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.4.2. Rest of Middle East and Africa Adrenocorticotropic hormone, By Source, 2017-2030(US$ Billions)
16.5.4.3. Rest of Middle East and Africa Adrenocorticotropic hormone, By Application, 2017-2030(US$ Billions)
16.5.4.4. Rest of Middle East and Africa Adrenocorticotropic hormone, By End-User, 2017-2030 (US$ Billions)
16.5.4.5. Rest of Middle East and Africa Adrenocorticotropic hormone, By Distribution Channel, 2017-2030 (US$ Billions)

17. Company Profiles
17.1. Pfizer Inc. (US)
17.1.1. Company Overview
17.1.2. Sources/Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. GlaxoSmithKline plc (UK)
17.3. Novartis AG (Switzerland)
17.4. Hikma Pharmaceuticals PLC (UK)
17.5. Merck & Co., Inc. (US)
17.6. Mallinckrodt (US)
17.7. Avantor, Inc. (US)
17.8. Merck KGaA (Germany)
17.9. Ferring B.V. (Switzerland)
17.10. Viatris, Inc. (US)

List of Figures
FIG. 1 Global Adrenocorticotropic hormone market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Adrenocorticotropic hormone market Segmentation
FIG. 4 Global Adrenocorticotropic hormone market, By Source, 2022(US$ Billions)
FIG. 5 Global Adrenocorticotropic hormone market, By Application, 2022(US$ Billions)
FIG. 6 Global Adrenocorticotropic hormone market, By End-User, 2022 (US$ Billions)
FIG. 7 Global Adrenocorticotropic hormone market, By Distribution Channel, 2022 (US$ Billions)
FIG. 8 Global Adrenocorticotropic hormone market, by Geography, 2022(US$ Billions)
FIG. 9 Attractive Investment Proposition, By Source, 2022
FIG. 10 Attractive Investment Proposition, By Application, 2022
FIG. 11 Attractive Investment Proposition, By End-User, 2022
FIG. 12 Attractive Investment Proposition, By Distribution Channel, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Adrenocorticotropic hormone market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Adrenocorticotropic hormone market Manufacturers, 2022
FIG. 16 Global Adrenocorticotropic hormone market Value Contribution, By Source, 2022&2030 (Value %)
FIG. 17 Global Adrenocorticotropic hormoneMarket, by Natural, Value, 2017-2030(US$ Billions)
FIG. 18 Global Adrenocorticotropic hormoneMarket, by Synthetic, Value, 2017-2030(US$ Billions)
FIG. 19 Global Adrenocorticotropic hormone market Value Contribution, By Application, 2022&2030 (Value %)
FIG. 20 Global Adrenocorticotropic hormoneMarket, by Rheumatology, Value, 2017-2030(US$ Billions)
FIG. 21 Global Adrenocorticotropic hormoneMarket, by Neurology, 2017-2030(US$ Billions)
FIG. 22 Global Adrenocorticotropic hormone market, by Nephrotic Syndrome, 2017-2030(US$ Billions)
FIG. 23 Global Adrenocorticotropic hormone market, by Ophthalmology, 2017-2030(US$ Billions)
FIG. 24 Global Adrenocorticotropic hormone market, by Others, 2017-2030(US$ Billions)
FIG. 25
FIG. 26 Global Adrenocorticotropic hormone market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 27 Global Adrenocorticotropic hormone market, by Hospitals, Value, 2017-2030 (US$ Billions)
FIG. 28 Global Adrenocorticotropic hormone market, by Specialty Clinics, 2017-2030 (US$ Billions)
FIG. 29 Global Adrenocorticotropic hormone market, by Homecare, 2017-2030 (US$ Billions)
FIG. 30 Global Adrenocorticotropic hormone market, by Others, 2017-2030 (US$ Billions)
FIG. 31 Global Adrenocorticotropic hormone market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 32 Global Adrenocorticotropic hormone market, by Hospitals Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 33 Global Adrenocorticotropic hormone market, by Retail Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 34 Global Adrenocorticotropic hormone market, by Online Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 35 Global Adrenocorticotropic hormone market, by Others, Value, 2017-2030 (US$ Billions)
FIG. 36 North America Adrenocorticotropic hormone market, 2017-2030 (US$ Billions)
FIG. 37 U.S. Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 38 Canada Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 39 Europe Adrenocorticotropic hormone market, 2017-2030 (US$ Billions)
FIG. 40 Germany Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 41 France Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 42 U.K. Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 43 Italy Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 44 Spain Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 45 Rest of Europe Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 46 Asia Pacific Adrenocorticotropic hormone market, 2017-2030 (US$ Billions)
FIG. 47 China Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 48 Japan Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 49 India Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 50 South Korea Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 51 South-East Asia Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 52 Rest of Asia Pacific Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 53 Latin America Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 54 Brazil Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 55 Mexico Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 56 Rest of Latin America Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 57 Middle East & Africa Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 58 GCC Countries Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 59 South Africa Adrenocorticotropic hormone market, 2017-2030(US$ Billions)
FIG. 60 Rest of Middle East and Africa Adrenocorticotropic hormone market, 2017-2030(US$ Billions)

List of Tables
TABLE 1 Market Snapshot: Global Adrenocorticotropic hormoneMarket
TABLE 2 Global Adrenocorticotropic hormone market: Market Drivers Impact Analysis
TABLE 3 Global Adrenocorticotropic hormone market: Market Restraints Impact Analysis
TABLE 4 Global Adrenocorticotropic hormone market, by Competitive Benchmarking,2022
TABLE 5 Global Adrenocorticotropic hormone market, by Geographical Presence Analysis, 2022
TABLE 6 Global Adrenocorticotropic hormone market, by Key Strategies Analysis, 2022
TABLE 7 Global Adrenocorticotropic hormone market, by Natural, By Region, 2017-2022(US$ Billions)
TABLE 8 Global Adrenocorticotropic hormone market, by Synthetic, By Region, 2023-2030(US$ Billions)
TABLE 9 Global Adrenocorticotropic hormone market, by Rheumatology, By Region, 2017-2022(US$ Billions)
TABLE 10 Global Adrenocorticotropic hormone market, by Rheumatology, By Region, 2023-2030(US$ Billions)
TABLE 11 Global Adrenocorticotropic hormone market, by Neurology, By Region, 2017-2022(US$ Billions)
TABLE 12 Global Adrenocorticotropic hormone market, by Neurology, By Region, 2023-2030(US$ Billions)
TABLE 13 Global Adrenocorticotropic hormone market, by Nephrotic Syndrome, By Region, 2017-2022(US$ Billions)
TABLE 14 Global Adrenocorticotropic hormone market, by Nephrotic Syndrome, By Region, 2023-2030(US$ Billions)
TABLE 15 Global Adrenocorticotropic hormone market, by Ophthalmology, By Region, 2017-2022(US$ Billions)
TABLE 16 Global Adrenocorticotropic hormone market, by Ophthalmology, By Region, 2023-2030(US$ Billions)
TABLE 17 Global Adrenocorticotropic hormone market, by Others, By Region, 2017-2022(US$ Billions)
TABLE 18 Global Adrenocorticotropic hormone market, by Others, By Region, 2023-2030(US$ Billions)
TABLE 19 Global Adrenocorticotropic hormone market, by Hospitals, By Region, 2017-2022(US$ Billions)
TABLE 20 Global Adrenocorticotropic hormone market, by Hospitals, By Region, 2023-2030(US$ Billions)
TABLE 21 Global Adrenocorticotropic hormone market, by Specialty Clinics, By Region, 2017-2022(US$ Billions)
TABLE 22 Global Adrenocorticotropic hormone market, by Specialty Clinics, By Region, 2023-2030(US$ Billions)
TABLE 23 Global Adrenocorticotropic hormone market, by Homecare, By Region, 2017-2022(US$ Billions)
TABLE 24 Global Adrenocorticotropic hormone market, by Homecare, By Region, 2023-2030(US$ Billions)
TABLE 25 Global Adrenocorticotropic hormone market, by Others, By Region, 2017-2022(US$ Billions)
TABLE 26 Global Adrenocorticotropic hormone market, by Others, By Region, 2023-2030(US$ Billions)
TABLE 27 Global Adrenocorticotropic hormone market, by Hospital Pharmacy, By Region, 2017-2022(US$ Billions)
TABLE 28 Global Adrenocorticotropic hormone market, by Hospital Pharmacy, By Region, 2023-2030(US$ Billions)
TABLE 29 Global Adrenocorticotropic hormone market, by Retail Pharmacy, By Region, 2017-2022(US$ Billions)
TABLE 30 Global Adrenocorticotropic hormone market, by Retail Pharmacy, By Region, 2023-2030(US$ Billions)
TABLE 31 Global Adrenocorticotropic hormone market, by Online Pharmacy, By Region, 2017-2022(US$ Billions)
TABLE 32 Global Adrenocorticotropic hormone market, by Online Pharmacy, By Region, 2023-2030(US$ Billions)
TABLE 33 Global Adrenocorticotropic hormone market, by Others, By Region, 2017-2022(US$ Billions)
TABLE 34 Global Adrenocorticotropic hormone market, by Others, By Region, 2023-2030(US$ Billions)
TABLE 35 Global Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 36 Global Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 37 Global Adrenocorticotropic hormone market, By Application, 2017-2022(US$ Billions)
TABLE 38 Global Adrenocorticotropic hormone market, By Application, 2023-2030(US$ Billions)
TABLE 39 Global Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 40 Global Adrenocorticotropic hormone market, By End-User, 2023-2030 (US$ Billions)
TABLE 41 Global Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 42 Global Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 43 Global Adrenocorticotropic hormone market, by Region, 2017-2022(US$ Billions)
TABLE 44 Global Adrenocorticotropic hormone market, by Region, 2023-2030(US$ Billions)
TABLE 45 North America Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 46 North America Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 47 North America Adrenocorticotropic hormone market, By Application, 2017-2022(US$ Billions)
TABLE 48 North America Adrenocorticotropic hormone market, By Application, 2023-2030(US$ Billions)
TABLE 49 North America Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 50 North America Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 51 North America Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 52 North America Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 53 North America Adrenocorticotropic hormone market, by Country, 2017-2022(US$ Billions)
TABLE 54 North America Adrenocorticotropic hormone market, by Country, 2023-2030(US$ Billions)
TABLE 55 United States Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 56 United States Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 57 United States Adrenocorticotropic hormone market, By Application, 2017-2022(US$ Billions)
TABLE 58 United States Adrenocorticotropic hormone market, By Application, 2023-2030(US$ Billions)
TABLE 59 United States Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 60 United States Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 61 United States Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 62 United States Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 63 Canada Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 64 Canada Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 65 Canada Adrenocorticotropic hormone market, by Applications, 2017-2022(US$ Billions)
TABLE 66 Canada Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 67 Canada Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 68 Canada Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 69 Canada Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 70 Canada Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 71 Mexico Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 72 Mexico Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 73 Mexico Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 74 Mexico Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 75 Mexico Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 76 Mexico Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 77 Mexico Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 78 Mexico Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 79 Europe Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 80 Europe Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 81 Europe Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 82 Europe Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 83 Europe Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 84 Europe Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 85 Europe Adrenocorticotropic hormone market, by Distribution Channel, 2017-2022(US$ Billions)
TABLE 86 Europe Adrenocorticotropic hormone market, by Distribution Channel, 2023-2030(US$ Billions)
TABLE 87 Germany Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 88 Germany Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 89 Germany Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 90 Germany Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 91 Germany Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 92 Germany Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 93 Germany Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 94 Germany Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 95 France Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 96 France Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 97 France Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 98 France Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 99 France Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 100 France Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 101 France Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 102 France Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 103 United Kingdom Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 104 United Kingdom Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 105 United Kingdom Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 106 United Kingdom Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 107 United Kingdom Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 108 United Kingdom Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 109 United Kingdom Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 110 United Kingdom Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 111 Italy Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 112 Italy Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 113 Italy Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 114 Italy Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 115 Italy Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 116 Italy Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 117 Italy Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 118 Italy Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 119 Spain Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 120 Spain Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 121 Spain Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 122 Spain Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 123 Spain Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 124 Spain Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 125 Spain Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 126 Spain Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 127 Rest of Europe Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 128 Rest of Europe Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 129 Rest of Europe Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 130 Rest of Europe Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 131 Rest of Europe Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 132 Rest of Europe Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 133 Rest of Europe Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 134 Rest of Europe Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 135
TABLE 136 Asia Pacific Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 137 Asia Pacific Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 138 Asia Pacific Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 139 Asia Pacific Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 140 Asia Pacific Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 141 Asia Pacific Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 142 Asia Pacific Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 143 Asia Pacific Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 144 China Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 145 China Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 146 China Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 147 China Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 148 China Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 149 China Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 150 China Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 151 China Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 152 Japan Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 153 Japan Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 154 Japan Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 155 Japan Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 156 Japan Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 157 Japan Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 158 Japan Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 159 Japan Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 160 India Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 161 India Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 162 India Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 163 India Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 164 India Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 165 India Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 166 India Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 167 India Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 168 South Korea Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 169 South Korea Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 170 South Korea Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 171 South Korea Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 172 South Korea Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 173 South Korea Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 174 South Korea Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 175 South Korea Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 176 South-East Asia Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 177 South-East Asia Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 178 South-East Asia Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 179 South-East Asia Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 180 South-East Asia Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 181 South-East Asia Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 182 South-East Asia Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 183 South-East Asia Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 184 Rest of Asia Pacific Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 185 Rest of Asia Pacific Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 186 Rest of Asia Pacific Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 187 Rest of Asia Pacific Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 188 Rest of Asia Pacific Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 189 Rest of Asia Pacific Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 190 Rest of Asia Pacific Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 191 Rest of Asia Pacific Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 192 Latin America Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 193 Latin America Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 194 Latin America Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 195 Latin America Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 196 Latin America Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 197 Latin America Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 198 Latin America Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 199 Latin America Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 200 Brazil Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 201 Brazil Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 202 Brazil Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 203 Brazil Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 204 Brazil Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 205 Brazil Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 206 Brazil Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 207 Brazil Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 208 Argentina Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 209 Argentina Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 210 Argentina Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 211 Argentina Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 212 Argentina Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 213 Argentina Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 214 Argentina Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 215 Argentina Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 216 Rest of Latin America Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 217 Rest of Latin America Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 218 Rest of Latin America Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 219 Rest of Latin America Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 220 Rest of Latin America Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 221 Rest of Latin America Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 222 Rest of Latin America Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 223 Rest of Latin America Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 224 Middle East and Africa Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 225 Middle East and Africa Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 226 Middle East and Africa Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 227 Middle East and Africa Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 228 Middle East and Africa Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 229 Middle East and Africa Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 230 Middle East and Africa Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 231 Middle East and Africa Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 232 GCC Countries Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 233 GCC Countries Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 234 GCC Countries Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 235 GCC Countries Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 236 GCC Countries Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 237 GCC Countries Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 238 GCC Countries Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 239 GCC Countries Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 240 South Africa Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 241 South Africa Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 242 South Africa Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 243 South Africa Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 244 South Africa Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 245 South Africa Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 246 South Africa Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 247 South Africa Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 248 Rest of Middle East and Africa Adrenocorticotropic hormone market, By Source, 2017-2022(US$ Billions)
TABLE 249 Rest of Middle East and Africa Adrenocorticotropic hormone market, By Source, 2023-2030(US$ Billions)
TABLE 250 Rest of Middle East and Africa Adrenocorticotropic hormone market, by Application, 2017-2022(US$ Billions)
TABLE 251 Rest of Middle East and Africa Adrenocorticotropic hormone market, by Application, 2023-2030(US$ Billions)
TABLE 252 Rest of Middle East and Africa Adrenocorticotropic hormone market, By End-User, 2017-2022(US$ Billions)
TABLE 253 Rest of Middle East and Africa Adrenocorticotropic hormone market, By End-User, 2023-2030(US$ Billions)
TABLE 254 Rest of Middle East and Africa Adrenocorticotropic hormone market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 255 Rest of Middle East and Africa Adrenocorticotropic hormone market, By Distribution Channel, 2023-2030(US$ Billions)

Frequently Asked Questions

What is the current size of the global Adrenocorticotropic Hormone Market?

The global Adrenocorticotropic Hormone Market was valued at USD 1.5 Billion in 2022.

What is the expected growth rate of the Adrenocorticotropic Hormone Market between 2023 and 2030?

The Adrenocorticotropic Hormone Market is expected to grow at a CAGR of 4.10% between 2023 and 2030, reaching USD 1.98 Billion in 2030.

Which segment is leading the market share in terms of Source?

The synthetic segment dominates the Adrenocorticotropic hormone market in 2022.

Which end-user segment governs the demand for Adrenocorticotropic Hormones in the world?

The Hospital segment governs the demand for Adrenocorticotropic Hormones in the world.

Which segment is expected to post the highest CAGR during the forecast period?

In 2022, the Nephrotic Syndrome category is predicted to develop at a 7.3% CAGR.

Which region is fueling the growth of the Adrenocorticotropic Hormone industry?

North America accounts for roughly 40% of the Adrenocorticotropic hormone market.

Who are the major players in the global Adrenocorticotropic Hormone Market?

The top players include Novartis AG, Hikma Pharmaceuticals PLC, Merck & Co., Inc. and Mallinckrodt.

What are the major market drivers of the Adrenocorticotropic Hormone industry?

Increasing Interest in Personalized Medicine, and Hormone Replacement Therapy is becoming more popular are the major market drivers.

What are the major market restraints of the Adrenocorticotropic Hormone industry?

ACTH tests are expensive and unreimbursed, and adrenal gland disorders are underappreciated are the major market restraints.

What are the major market opportunities of the Adrenocorticotropic Hormone industry?

Adrenal gland problems are becoming more common, and ACTH tests are becoming more popular in developing countries are the major opportunities in the Adrenocorticotropic Hormone industry.

Cervical Total Disc Replacement Market

Published:
Report ID: 36030

Aseptic Sampling Market

Published:
Report ID: 36018

Capillary Blood Collection Devices Market

Published:
Report ID: 36014

Contrast Media Market

Published:
Report ID: 36005

Medical Adhesive Tapes Market

Published:
Report ID: 35998

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Tooth Filling Materials Market

Published:
Report ID: 35987

US Retail Pharmacy Market

Published:
Report ID: 32801

Nanomedicine Therapeutics Market

Published:
Report ID: 35961

Liposomes Market

Published:
Report ID: 35888

Triple Negative Breast Cancer Market

Published:
Report ID: 35843

Colorectal Cancer Screening and Diagnostic Market

Published:
Report ID: 35780

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN